# Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

> **NCT05108935** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 17 (actual)

## Conditions studied

- Opioid Use
- Opioid Use Disorder
- Risk Reduction
- Hiv
- Hepatitis C

## Interventions

- **DRUG:** Suboxone
- **DRUG:** Truvada
- **DRUG:** Mavyret

## Key facts

- **NCT ID:** NCT05108935
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-17
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2023-04-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05108935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05108935, "Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05108935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*